Cortexyme, Inc. CRTX
Institutional shares held
7.27 Million
103K
calls
0
puts
Total value of holdings
$9.38M
$133K
calls
$0
puts
Market Cap
$70.5M
36,150,800
Shares Out.
Institutional ownership
20.11%
# of Institutions
48
We take great care to ensure that the data presented and summarized in this overview for Cortexyme, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CRTX
View all-
Tang Capital Management LLC San Diego, CA2.95MShares$3.8 Million0.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.13MShares$1.46 Million0.0% of portfolio
-
Epiq Capital Group, LLC San Francisco, CA846KShares$1.09 Million0.43% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny520KShares$670,9290.0% of portfolio
-
Black Rock Inc. New York, NY332KShares$428,3900.0% of portfolio
-
Geode Capital Management, LLC Boston, MA267KShares$344,2950.0% of portfolio
-
Alphabet Inc. Mountain View, CA189KShares$243,9670.01% of portfolio
-
Bank Of America Corp Charlotte, NC170KShares$219,1720.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX138KShares$178,6580.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny97.1KShares$125,2590.0% of portfolio
Latest Institutional Activity in CRTX
Top Purchases
Top Sells
About CRTX
Insider Transactions at CRTX
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 16
2024
|
Dirk Thye CEO AND CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
240,530
+16.12%
|
$0
$0.75 P/Share
|
|
Dec 14
2023
|
David Lamond Director |
BUY
Open market or private purchase
|
Indirect |
22,627
+0.95%
|
$22,627
$1.04 P/Share
|
|
Dec 13
2023
|
David Lamond Director |
BUY
Open market or private purchase
|
Indirect |
22,627
+0.96%
|
$22,627
$1.0 P/Share
|
|
Dec 12
2023
|
David Lamond Director |
BUY
Open market or private purchase
|
Direct |
22,327
+0.96%
|
$22,327
$1.02 P/Share
|
|
Dec 12
2023
|
David Lamond Director |
BUY
Open market or private purchase
|
Indirect |
300
+0.01%
|
$300
$1.0 P/Share
|
|
Dec 07
2023
|
David Lamond Director |
BUY
Open market or private purchase
|
Indirect |
19,123
+0.83%
|
$19,123
$1.01 P/Share
|
|
Dec 06
2023
|
David Lamond Director |
BUY
Open market or private purchase
|
Indirect |
19,123
+0.84%
|
$19,123
$1.02 P/Share
|
|
Dec 05
2023
|
David Lamond Director |
BUY
Open market or private purchase
|
Indirect |
19,123
+0.85%
|
$19,123
$1.01 P/Share
|
|
Dec 01
2023
|
David Lamond Director |
BUY
Open market or private purchase
|
Indirect |
14,378
+0.64%
|
$0
$0.94 P/Share
|
|
Nov 30
2023
|
David Lamond Director |
BUY
Open market or private purchase
|
Indirect |
14,378
+0.65%
|
$0
$0.9 P/Share
|
|
Nov 29
2023
|
David Lamond Director |
BUY
Open market or private purchase
|
Indirect |
14,378
+0.65%
|
$0
$0.98 P/Share
|
|
Aug 31
2023
|
David Lamond Director |
BUY
Open market or private purchase
|
Indirect |
41,026
+1.85%
|
$41,026
$1.32 P/Share
|
|
Aug 30
2023
|
David Lamond Director |
BUY
Open market or private purchase
|
Indirect |
41,026
+1.88%
|
$41,026
$1.31 P/Share
|
|
Aug 17
2023
|
David Lamond Director |
BUY
Open market or private purchase
|
Indirect |
24,766
+1.17%
|
$24,766
$1.29 P/Share
|
|
Aug 16
2023
|
David Lamond Director |
BUY
Open market or private purchase
|
Indirect |
117,348
+5.36%
|
$117,348
$1.29 P/Share
|
|
Aug 15
2023
|
David Lamond Director |
BUY
Open market or private purchase
|
Indirect |
107,886
+5.23%
|
$107,886
$1.32 P/Share
|
|
Aug 10
2023
|
Dirk Thye CEO AND CHIEF MEDICAL OFFICER |
BUY
Open market or private purchase
|
Direct |
88,000
+16.39%
|
$88,000
$1.26 P/Share
|
|
Aug 08
2023
|
Brendan Hannah CHIEF BUSINESS OFFICER AND COO |
BUY
Open market or private purchase
|
Direct |
71,762
+26.26%
|
$71,762
$1.22 P/Share
|
|
Aug 08
2023
|
Dirk Thye CEO AND CHIEF MEDICAL OFFICER |
BUY
Open market or private purchase
|
Direct |
80,000
+18.14%
|
$80,000
$1.24 P/Share
|
|
Aug 08
2023
|
Margaret Mc Loughlin Director |
BUY
Open market or private purchase
|
Direct |
8,000
+50.0%
|
$8,000
$1.23 P/Share
|
Last 12 Months Summary
Buy / Acquisition
989K
Shares
From
5
Insiders
| Open market or private purchase | 748K shares |
|---|---|
| Exercise of conversion of derivative security | 241K shares |
Sell / Disposition
0
Shares
From
0
Insiders